Healthcare / Medical Care FacilitiesThailand
$3.68
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 25%
FCF escenarios
weak_data · normalized FCF $250.9M · quality 67.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
54/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.6B
P/E
13.6x
↓EV/EBITDA
6.0x
↓ROE
10.0%
↑Gross Margin
28.6%
↓Debt/Equity
0.19
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.3%
FCF CAGR
+14.6%
FCF margin
15.4%
FCF / Net income
2.03x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.59B · net income $196.6M · FCF $398.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.59B | $2.59B | $2.40B | $2.23B | $2.42B |
| Net Income | $196.6M | $196.6M | $78.2M | $63.6M | $322.9M |
| EBITDA | $484.3M | $484.3M | $341.0M | $297.5M | $541.9M |
| EPS | 0.27 | 0.27 | 0.11 | 0.09 | 0.45 |
| Gross Margin | 28.6% | 28.6% | 24.0% | 21.2% | 28.9% |
| Operating Margin | 9.2% | 9.2% | 3.5% | 3.3% | 15.6% |
| Net Margin | 7.6% | 7.6% | 3.3% | 2.8% | 13.4% |
| Balance Sheet | |||||
| Debt/Equity | 0.19 | 0.19 | 0.29 | 0.27 | 0.21 |
| Current Ratio | 1.62 | 1.62 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $398.3M | $398.3M | $250.9M | $-36.0M | $264.8M |
| Returns | |||||
| ROE | 10.0% | 10.0% | 4.1% | 3.2% | 16.1% |
| Valuation | |||||
| P/E | 13.63 | 13.63 | 39.27 | 58.82 | 12.44 |
| EV/EBITDA | 6.03 | 6.03 | 10.46 | 14.28 | 7.91 |
| P/B | 1.35 | 1.35 | 1.63 | 1.95 | 2.01 |
| Growth & Yield | |||||
| Revenue Growth | 7.6% | 7.6% | 7.6% | -7.6% | — |
| EPS Growth | 145.5% | 145.5% | 22.2% | -80.0% | — |
| Dividend Yield | 10.8% | 10.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
6.5%
EPS terminal req.
$0.33
Spread vs growth
138.9%
5Y implied EPS CAGR
7.9%
EPS terminal req.
$0.40
Spread vs growth
137.5%
10Y implied EPS CAGR
9.0%
EPS terminal req.
$0.64
Spread vs growth
136.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+6.7%
Start / end P/E
35.1x → 13.7x
EPS bridge
0.11 → 0.27
Residual
-88.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.